AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-2071639_ITM" title="Facts and information about Spectinomycin Is Back on the Market for Now. (For N. Gonorrhoeae).">Spectinomycin Is Back on the Market for Now. (For N. Gonorrhoeae).</a>
Close
Set up an RSS feed that alerts you when new articles from OB GYN News are available.
Frequently asked questions about RSS feeds
Spectinomycin Is Back on the Market for Now. (For N. Gonorrhoeae).
Spectinomycin is available again-at least until December 31.
The drug, recommended for the treatment of Neisseria gonorrhoeae in patients who can't take cephalosporins or fluoroquinolones, was discontinued by Pharmacia Corp., Peapack, N.J., earlier this year due to low sales, and was believed to have expired June 30.
However, examination of existing inventory revealed that the ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- FDA probes "misleading" journal article. (Washington Insider).(U.S. Food and...
- Magazine article from: Medical Marketing & Media Dickinson, James G. August 1, 2002 700+ words
The FDA is looking into whether Pharmacia Corp. knowingly disseminated an allegedly misleading journal article on Celebrex (celecoxib), according to a senior agency official...
- Pharmacia approvals. (RXs).(Pharmacia Corp. receives Food and Drug...
- Magazine article from: Chain Drug Review January 20, 2003 700+ words
...initial treatment for elevated eye pressure. The product, the first prescription eye drop in its class, was developed by Pharmacia Corp. The company has also obtained clearance for Zyvox for the treatment of bacterial infections in infants and children.
- Arthritis drugs. (RXs).(Amgen Inc. and Pharmacia Corp. receive Food and Drug...
- Magazine article from: Chain Drug Review December 10, 2001 700+ words
Amgen Inc. has received FDA approval for Kineret, a drug for rheumatoid arthritis. Pharmacia Corp. has been given clearance for Bextra, a follow-up to its popular painkiller marketed under the Celebrex name.
- Somatropin injection.(Novo Nordisk A/s and Pharmacia Corp.)(Brief Article)
- Magazine article from: Chain Drug Review July 17, 2000 700+ words
The Food and Drug Administration has approved separate marketing requests by Novo Nordisk A/S and Pharmacia Corp. for somatropin [rDNA origin] injection for the long-term treatment of children who have growth failure. The former will...
- PRESS RELEASE: Pharmacia Corp and Pfizer Inc receive approvable letter for...
- News wire article from: Chemical Business Newsbase April 18, 2001 700+ words
Pharmacia Corp and Pfizer Inc have received...letter from the US Food and Drug Administration (FDA) for revised labelling...The drug is marketed by Pharmacia Corp and Pfizer Inc. Pharmacia Corp is a leading global pharmaceutical...
- Pharmacia Corp.(shares fall)(Brief Article)(Statistical Data Included)
- News wire article from: Drug Store News - NewsFirst July 18, 2001 700+ words
PEAPACK, N.J. -- Shares of Pharmacia Corp. fell almost 9 percent Monday after the company reported that the Food and Drug Administration issued a "non-approvable" letter for its new injectable painkiller parecoxib sodium. The FDA requested...
- PRESS RELEASE: Pharmacia Corp announces trademark suit against Alcon, a...
- News wire article from: Chemical Business Newsbase April 11, 2001 700+ words
Pharmacia Corp believes that its...by the US Food and Drug Administration on 16 Mar 2001. Alcon...ophthalmic product. Pharmacia Corp is a leading global...owned subsidiary of Pharmacia Corp. Pharmacia Corp...
- Cauley Geller announces class action lawsuit against Pharmacia Corp on behalf...
- News wire article from: Asia Africa Intelligence Wire April 15, 2003 700+ words
...on behalf of purchasers of Pharmacia Corp's publicly traded securities...Period). The complaint charges Pharmacia Corp and certain of its officers...efforts to have the Food and Drug Administration remove the warning label from...
- Pharmacia Corp. to Spin Off Rest of Monsanto Subsidiary.
- Newspaper article from: Knight Ridder/Tribune Business News November 29, 2001 700+ words
...Cementing its push to be a top-tier drug maker, Pharmacia Corp. will jettison its remaining stake in the agricultural...submit an application for Eplerenone with the Food and Drug Administration early next year. Two compounds licensed from other companies...
- Press Release: Pharmacia Corp announces voluntary recall of Lunelle Monthly...
- News wire article from: Asia Africa Intelligence Wire October 10, 2002 700+ words
...From Chemical Business NewsBase: Press Release) Pharmacia Corp is initiating a voluntary recall of Lunelle Monthly...recall with the full knowledge of the Food and Drug Administration. The affected lots were distributed in the US...
Source: HighBeam Research, Spectinomycin Is Back on the Market for Now. (For N. Gonorrhoeae).